Japan Mulls Pricing Changes, Generic Sector Review Amid Ongoing Shortages

Set Of New Govt Proposals

 
• By Lisa Takagi
  
Japan's MHLW had a dedicated committee discussing the drug shortage until June 2023
Japan's MHLW suggests need for further discussions, regulations and pricing changes to address drug shortages • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Japan

More from Asia